Hilltop (NYSE:HTH) posted its quarterly earnings data on Thursday. The financial services provider reported $0.62 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.38 by $0.24, Briefing.com reports. Hilltop had a net margin of 8.30% and a return on equity of 6.90%. The company had revenue of $420.75 million for the quarter, compared to analyst estimates of $380.83 million. During the same period in the prior year, the company posted $0.35 EPS.
HTH stock traded up $0.01 during mid-day trading on Friday, reaching $22.50. The company had a trading volume of 1,079,400 shares, compared to its average volume of 442,228. The company has a debt-to-equity ratio of 0.03, a current ratio of 0.98 and a quick ratio of 0.88. The stock has a market cap of $2.11 billion, a P/E ratio of 17.58 and a beta of 0.88. The business has a 50 day moving average of $21.04. Hilltop has a 12 month low of $16.43 and a 12 month high of $23.38.
In other Hilltop news, insider Hill A. Feinberg sold 40,000 shares of the company’s stock in a transaction dated Monday, June 3rd. The shares were sold at an average price of $20.26, for a total value of $810,400.00. Following the transaction, the insider now directly owns 809,153 shares in the company, valued at approximately $16,393,439.78. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 21.20% of the stock is owned by corporate insiders.
A number of analysts recently weighed in on HTH shares. Zacks Investment Research lowered shares of German American Bancorp. from a “buy” rating to a “hold” rating in a research report on Tuesday, April 30th. TheStreet downgraded shares of Weyco Group from a “b-” rating to a “c+” rating in a research note on Friday, July 19th. Piper Jaffray Companies restated a “hold” rating on shares of Seattle Genetics in a research note on Thursday, March 28th. ValuEngine downgraded shares of Acceleron Pharma from a “strong-buy” rating to a “buy” rating in a research note on Thursday, April 18th. Finally, Stephens dropped their target price on shares of O’Reilly Automotive from $440.00 to $430.00 and set an “overweight” rating on the stock in a research note on Friday. Three equities research analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the stock. Hilltop presently has an average rating of “Buy” and an average target price of $22.50.
Hilltop Holdings Inc provides banking and financial products and services. The company operates in four segments: Banking, Broker-Dealer, Mortgage Origination, and Insurance. The Banking segment offers savings, checking, interest-bearing checking, and money market accounts; certificates of deposit; lines and letters of credit, home improvement and equity loans, loans for purchasing and carrying securities, equipment loans and leases, agricultural and commercial real estate loans, and other loans; and commercial and industrial loans, and term and construction finance.
Further Reading: Swap
Receive News & Ratings for Hilltop Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hilltop and related companies with MarketBeat.com's FREE daily email newsletter.